GlassScriptPhysician profile
Joyce Freidly
NPI 1457421588
$10,452.21
in general payments reported to CMS, 2019-2025
41 companies · $1,756 in 2025
The $1,756 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $561 · 2022: $1,331 · 2023: $2,012 · 2024: $4,793 · 2025: $1,756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,494 · Honoraria: $1,575 · Travel and Lodging: $1,279 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $112 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,494.40 |
| Honoraria | $1,575.00 |
| Travel and Lodging | $1,279.36 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $111.79 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $3,274.81 | 2023-2024 | |
| Janssen Biotech, INC. | $1,253.27 | 2021-2025 | Erleada, Akeega, Carvykti |
| Bayer Healthcare Pharmaceuticals INC. | $775.76 | 2021-2025 | |
| Abbvie INC. | $598.21 | 2021-2025 | |
| Astellas Pharma US INC | $459.18 | 2021-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $372.93 | 2023-2025 | Orgovyx, Gemtesa |
| Dendreon Pharmaceuticals LLC | $367.64 | 2021-2025 | Provenge |
| Medtronic, INC. | $322.00 | 2022-2024 | Interstim |
| Pfizer INC. | $226.91 | 2022-2025 | |
| Endo Pharmaceuticals INC. | $225.94 | 2021-2024 | Xiaflex, Aveed |
| Astrazeneca Pharmaceuticals LP | $206.05 | 2022-2025 | Lynparza |
| Teleflex LLC | $189.83 | 2022-2025 | Barrigel, Urolift |
| Olympus America INC. | $188.31 | 2023-2025 | Itind System |
| Novartis Pharmaceuticals Corporation | $187.95 | 2023-2025 | |
| Amgen INC. | $161.04 | 2021-2024 | Prolia, Evenity, Xgeva |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $159.73 | 2023-2024 | |
| Ferring Pharmaceuticals INC. | $151.57 | 2024-2025 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $150.96 | 2022-2025 | Pylarify |
| Merck Sharp & Dohme LLC | $144.07 | 2021-2025 | Keytruda, Lynparza |
| Janssen Scientific Affairs, LLC | $118.22 | 2021-2025 | Erleada |
| Tempus Ai, INC | $95.63 | 2024-2025 | Xt Cdx |
| Myovant Sciences INC. | $85.33 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $84.74 | 2021-2022 | |
| Caris Mpi, INC. | $82.23 | 2025 | Mi Cancer Seek |
| Urovant Sciences INC | $69.57 | 2021-2022 | |
| 180 Medical, INC. | $49.43 | 2022-2024 | Gentlecath |
| Endo USA, INC. | $49.26 | 2024-2025 | Xiaflex, Aveed |
| Foundation Medicine, INC. | $45.04 | 2021-2023 | Foundationone Cdx |
| Bioprotect Medical, INC. | $44.84 | 2025 | Bioprotect Balloon Implant System |
| Boston Scientific Corporation | $38.68 | 2022 | |
| Abbott Laboratories | $34.20 | 2025 | Proclaim |
| Myriad Genetic Laboratories, INC. | $34.06 | 2022-2024 | Prolaris |
| Telix Pharmaceuticals | $28.40 | 2023 | Illuccix |
| Urogen Pharma, INC. | $27.63 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $26.15 | 2025 | Opdivo |
| Immunitybio, INC. | $24.92 | 2024 | |
| Mission Pharmacal Company | $21.37 | 2023 | Uribel |
| Vertex Pharmaceuticals Incorporated | $21.15 | 2025 | |
| Clovis Oncology, INC. | $20.67 | 2021 | |
| Antares Pharma, INC. | $19.70 | 2021 | |
| Blue Earth Diagnostics | $14.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Freidly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.